Fri, May 3, 2024

Salveen Richter Maintained (AGIO) at Hold with Increased Target to $33 on, May 3rd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-33-on-may-3rd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Salveen Richter of Goldman Sachs, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Increased Target from $29 to $33 on, May 3rd, 2024.

Salveen has made no other calls on AGIO in the last 4 months.



There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $30 on, Friday, February 23rd, 2024


These are the ratings of the 2 analyists that currently disagree with Salveen


  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, April 9th, 2024
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $42 on, Friday, February 16th, 2024

Publication Contributing Sources